Filing Details

Accession Number:
0001415889-24-020009
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-07-23 21:05:12
Reporting Period:
2024-07-22
Accepted Time:
2024-07-23 21:05:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2010135 John Fesko C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
President, Chief Bus. Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-07-22 549 $105.16 109,391 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 22, 2021 and January 28, 2022.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.73 to $105.16 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.